Nicotine-Chomping Bacteria Could Help Smokers Quit

Researchers isolated a bacterial enzyme that could break down nicotine before smokers get the buzz that keeps them coming back for more. Christopher Intagliata reports

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!

Quitting smoking is tough—so tough that only about 5 percent of smokers who try to quit in a given year actually succeed. Medications can double those odds—which still leaves a high failure rate. And a promising vaccine, meant to arouse an immune response to nicotine, could not beat a placebo in clinical trials. But researchers haven't given up on a vaccine yet. Instead of revving up the immune system, though, they've come up with a new idea: why not use an enzyme to break down nicotine—before it gives you a buzz?

"For almost 50 years there's been reports of bacteria that can actually use nicotine to thrive on." Kim Janda, a chemist and immunologist at The Scripps Research Institute. "The bacteria uses nicotine as its sole source of carbon and nitrogen."

It does the trick with a nicotine-chomping enzyme. So Janda and his colleagues added the enzyme to mouse serum, doped with a cigarette's worth of nicotine. The enzyme was stable at human body temperature—and was able to cut the half-life of nicotine from a couple hours to less than 15 minutes—that is, it greatly accelerated nicotine’s disappearance. The study is in the Journal of the American Chemical Society. [Song Xue et al, A New Strategy for Smoking Cessation: Characterization of a Bacterial Enzyme for the Degradation of Nicotine]


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


But Janda says the enzyme isn't ready for primetime yet. It's bacterial—so "you're going to get an immune response, immune surveillance from it." And right now, the other important half-life, that of the enzyme in serum, is only 3 days. So it won’t stick around long enough to be an effective vaccine. "A month would be great, a week or two would also be reasonable." While the researchers work out the kinks, smokers will have to rely on the tried-and-true methods of quitting: counseling, medication or good old cold turkey.

—Christopher Intagliata

[The above text is a transcript of this podcast.]

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe